Shanghai Xingling TechnologyMedicineLtd.
|
| Parent Company |
|
| Website |
http://www.xingling.com.cn |
| Email |
|
| Products |
|
| Employee Number |
|
| Industry |
Pharmaceutical / biotechnology |
| Settle Date |
|
|
|
| About Us ： |
| Shanghai Xing Ling Sci. & Tech. Pharmaceutical Co., Ltd., a high-tech sector of the Shanghai Pharmaceutical Group, possesses an exceptional R&D team. Our mission is to successfully develop, manufacture, and market high-quality modern Chinese and botanical drugs. |
| Introduce of Product： |
Xing Ling commits itself to the development of Ginkgo biloba products with dedication and professionalism, utilizing both specialized skills and recent technoloy. As the creator of standardized national regulations for the Ginkgo biloba product, Xing Ling has set up a rigorous quality-guarantee system that covers all aspects of drug production, from GAP Ginkgo agricultural practices to GMP manufacturing, and has thus established a core product of superior quality. The Sitailong tablet and Xingling Ginkgo granule contain less than 5 ppm of Ginkgo acid, and are patented in China, Britain, Australia, and the United States. Both products are listed in the National Catalogue of Insured Medicines in China.
From within the industrial center of Shanghai, Xing Ling has invested two hundred million RMB in the development of botanical extracts, helping to pave the path for a modernization of the nation's natural medicine industry. We have opened up a new area of specialization in the field of Ginkgo manufacturing, and will continue to expand our services to our core customers. Xing Ling is dedicated to maintaining a high degree of societal responsibility: we will offer high-quality and low-price Ginkgo products, promote health, and pass on the dream of a long and healthy life.
| |
|
|
